SERPINx's Corporate Minority Round

SERPINx raised a round of funding on December 29, 2017. Investors include ImmunoPrecise Antibodies.

SERPINx is a Dutch protein therapeutics company involved in developing novel serine protease inhibitor (serpin) therapeutics for inflammatory-associated diseases, in particular angioedema.…

Articles about SERPINx's Corporate Minority Round: